“June is one of the months dynamic months we’ll have in our history,” Chief Operating Officer Kate Haviland told the Business Journal.

Boston Biz Journal https://www.bizjournals.com/boston/news/2019/06/03/blueprint-medicines-readies-for-4-drug.html?ana=RSS&s=article_search